临床科研：作为学科带头人组织团队依靠国家骨科中心平台，牵头全国创伤（骨科等围手术期）合并心脏病诊疗及标准制定。建立骨质疏松合并心脏疾病的国际最大，最全的数据及科研平台基础研究：

1.继续完善北京自然科学基金：  巨噬细胞来源的外泌体对血管平滑肌细胞成骨向分化的调控 及作用研究 培养硕士及博士生

2.申请国家自然科学基金：成骨细胞外泌体lncRNA APF调节自噬对衰老诱发心室重塑的作用及机制研究  

临床科研：作为学科带头人组织团队依靠国家骨科中心平台，牵头全国创伤（骨科等围手术期）合并心脏病诊疗及标准制定。建立骨质疏松合并心脏疾病的国际最大，最全的数据及科研平台基础研究：

1.继续完善北京自然科学基金：  巨噬细胞来源的外泌体对血管平滑肌细胞成骨向分化的调控 及作用研究 培养硕士及博士生

2.申请国家自然科学基金：成骨细胞外泌体lncRNA APF调节自噬对衰老诱发心室重塑的作用及机制研究  

•基础研究： 动脉粥样硬化与冠脉钙化的机制研究

      北京自然科学基金（2023年1月-2025年12月）7232078 巨噬细胞来源的外泌体对血管平滑肌细胞成骨向分化的调控 及作用研究 面上 经费 20万元 在研课题负责人

      国家自然基金（ 2015年8月-2018年12月）81470429 miR-214对血管钙化的调控作用及其机制研究 面上 经费 72万元 结题课题负责人

•临床研究： 冠脉介入治疗及腔内影像

•血脂相关研究

•中国中青年临床研究基金（V.G） （2018 年 5 月——2021年 12 月）早发冠心病患者中家族性高胆固醇血症的精准诊断与预后研究  40 万元 结题 课题负责人

•血管健康中青年医师基金(2018-2021) 匹伐他汀在老年冠心病患者中的应用 5万 课题负责人

uYuTan (#), Yanqiao Yu, Wei Liu(*), Xiaojuan Ma(*) and Dazhuo Shi(*). Bibliometric evaluation of publications on inflammasomes inatherosclerosis from 2002 to 2022. Front. Cardiovasc. Med. doi:10.3389/fcvm.2023.1067226

uFanJ(#), Bai J, WeiLiu(*). ,Cai J(*). Effects of intensive vs. standard blood pressure control on cognitivefunction: Post-hoc analysis of the STEP randomized controlled trial. FrontNeurol. doi:10.3389/fneur.2023.1042637.

uYananGao(#), YuyangLiu(#), Sijing Wu, Ziwei Xi,Xu Wang, YujieZhou, Wei Liu(*). Therelationship between residual cholesterol risk and plaque characteristics inpatients with acute coronary syndrome: Insights from an optical coherencetomography study. Atherosclerosis. DOI: https://doi.org/10.1016/j.atherosclerosis.2020.11.033

uYonghao Lan,Wei Liu(*), YujieZhou. Right Ventricular Damage in COVID-19: Association Between MyocardialInjury and COVID-19. Front Cardiovasc Med. doi: 10.3389/fcvm.2021.606318.

uUrianhkai Horchinbilig(#), YananGao(#), Hong Chang, Pengfei Xi, Jinlong Wu,Jun Wang, Wei Liu(*).Investigation of 100 SARS-CoV-2 Infected Families in Wuhan: TransmissionPatterns and Effectiveness of Quarantine Measures. Journal of Global Health

uYakeLou(#), YananGao(#), Ying Yu, Yanli Li, Ziwei Xi, KhaingNyein Chan Swe, YujieZhou, Xiaomin Nie(*), Wei Liu(*).Efficacy and safety of transcatheter versus surgical aortic valve replacementin low-to-intermediate-risk patients: A meta-analysis. Frontiers inCardiovascular Medicine

uYushiWang(#), Yang Zheng, Qian Tong, Lihui Wang, Guorui Lv, Ziwei Xi, WeiLiu(*),Cardiac injury and clinical course of patients with Coronavirus Disease 2019,Frontiers in Cardiovascular Medicine. 

uFengLin (#), Ning Ruihong (#),Liu Jiangyan,Liang Shuang, Xu Qing, Liu Ying,Liu Wei (*), DuanJunchao (*),Sun Zhiwei.Silica nanoparticles induce JNK-mediated inflammation and myocardialcontractile dysfunction. J Hazard Mater. 2020;391:122206.

uXiZiwei (#),Zhou Yujie,Zhao Yingxin, LiuXiaoli,Liang Jing, Chai Meng, Yu Ying, LiuWei (*). TicagrelorVersus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function AllelesUndergoing Percutaneous Coronary Intervention. Cardiovasc Drugs Ther.2020;34(2):179‐188.

uZiwei Xi,Tong Liu, Jing Liang, Yu-JieZhou, Liu Wei (*). Impactof postprocedural permanent pacemaker implantation on clinical outcomes aftertranscatheter aortic valve replacement: a systematic review and meta-analysis.J Thorac Dis.doi:10.21037/jtd.2019.12.02.

uFanJ, Zheng W, WeiLiu(#), XuJ, Zhou L, Liu S, Bai J, Qi Y, Huang W, Liu K, Cai J. Cost-Effectiveness ofIntensive Versus Standard Blood Pressure Treatment in Older Patients WithHypertension in China. Hypertension. doi: 10.1161/HYPERTENSIONAHA.122.20051.

uYouzhouChen, XingshanZhao, JiansongYuan, Yan Zhang, WeiLiu(*),Shubin Qiao(*).Preoperative myocardial fibrosis is associated with worse survival afteralcohol septal ablation in patients with hypertrophic obstructivecardiomyopathy: A delayed enhanced cardiac magnetic resonance study. FrontCardiovasc Med. doi:10.3389/fcvm.2022.924804.

uYou-ZhouChen, Xing-Shan Zhao, Jian-Song Yuan, Yan Zhang, WeiLiu(*),Shu-Bin Qiao(*).Sex-related differences in left ventricular remodeling and outcome afteralcohol septal ablation in hypertrophic obstructive cardiomyopathy: insightsfrom cardiovascular magnetic resonance imaging. Biol Sex Differ. doi:10.1186/s13293-022-00447-x.

uLouYake (#),Yu Ying, Xi Ziwei, GaoYanan, Wei Liu(*), Nie Xiaomin (*).Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents VersusSecond-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis ofRandomized Controlled Trials. Cardiovasc Drugs Ther. 2019;33(5):557–566.

uXiZ (#), Gao Y, Yan Z, Zhou YJ, WeiLiu(*). ThePrognostic Significance of Different Bleeding Classifications in off-pumpcoronary artery bypass grafting. BMC Cardiovasc Disord. 2020;20(1):3.

uCaiG, Liu W (#), Lv S,Wang X, Guo Y, Yan Z, Du Y, Zhou Y (*). Gender-specific associations betweenatherogenic index of plasma and the presence and severity of acute coronarysyndrome in very young adults: a hospital-based observational study. LipidsHealth Dis. 2019;18(1):99.

uWangX (#), Cai G (#), Wang Y, Liu R, Xi Z, Li G, Wen W, Wu Y, Wang C, Ji Q, Wang X,Zhang Q, Zeng Y, Wang L,Liu W (*),Zhou Y (*). Comparison of long-term outcomes of young patients after a coronaryevent associated with familial hypercholesterolemia. Lipids Health Dis.2019;18(1):131. [

uLiuW(#),Zheng Junmeng,Song Deli, Dong Jianzeng, BaiRong, Ma Xiaohai,Zhao Lei, Yao Yan, Zhang Haibo, LiuTong(*). Association of miR-197-5p,a circulating biomarker for heart failure,with myocardial fibrosis and adverse cardiovascular events among patients withstage C or D heart failure[J]. Cardiology. 2018;141(4):212‐225.

uSaiLv(#); Wei Liu(#); YujieZhou(*); Yuyang Liu;Dongmei Shi;YingxinZhao; Xiaoli Liu,Hyperuricemia and smoking in young adults suspected of coronary artery disease≤ 35 years of age: a hospital-based observational study. BMC CardiovascularDisorders, 2018.12, 18(1): 0~178. 

uLvSai(#); Liu Wei(#);Zhou Yujie(*);Liu Yuyang; ShiDongmei;Zhao Yingxin; LiuXiaoli; AlhelalJumana W; Ravuru K S Shakeenah.Hyperuricemia and severity of coronary artery disease: An observational studyin adults 35 years of age and younger with acute coronary syndrome.(DOI:10.5603/CJ.a2018.0022), Cardiology Journal, 2019;26(3):275-282.

uLiuWei(#), XiZ(#), Gu C, Dong R, AlHelal J,Yan Z, Zhou Y(*). Impact of major bleeding on the risk of acute kidney injuryin patients undergoing off-pump coronary artery bypass grafting[J], Journal ofThoracic Disease, 2018.06, 10(6): 3381~3389.

uXiZ(#), Fang F, Wang J, AlHelal J,Zhou Y, Liu Wei(*).CYP2C19 genotype and adverse cardiovascular outcomes after stent implantationin clopidogrel-treated Asian populations: A systematic review andmeta-analysis[J]. Platelets, 2017(127):1-12.

uWuS(#), Liu Wei(#),Zhao Y, Shi D, Liu R, Wang J, Yu Y, Jia S, Sun Y, Zhou Y(*). Revascularizationtreatment for spontaneous coronary artery dissection: A reconsideration ofdrug-coated balloons and bioresorbable vascular scaffold[J]. InternationalJournal of Cardiology, 2016, 209:49-50.

uWuS(#), Liu Wei(#),Zhou Y(*). Spontaneous coronary artery dissection in the presence of myocardialbridge causing myocardial infarction: an insight into mechanism[J].International Journal of Cardiology, 2016, 206:77-78.

uAkhtarMuzina(#), Liu Wei(*). Useof intravascular ultrasound vs. optical coherence tomography for mechanism andpatterns of in-stent restenosis among bare metal stents and drug elutingstents. Journal of Thoracic Disease, 2016.01, 8(1): E104~E108.  

uLiu Wei(#);Zhang Yue; Yu Cheuk Man; Ji Qing Wei; Cai Meng; Zhao Ying Xin; Zhou Yu Jie(*).Current understanding of coronary artery calcification Journal of GeriatricCardiology, 2015, 12(6): 668~675.  

uLiu W(#),Ling S(#), Sun W, Liu T, Li Y, Zhong G, Zhao D, Zhang P, Song J, Jin X,Xu Z, Song H, Li Q, Liu S, Chai M, Dai Q, He Y, Fan Z, Zhou YJ(*), Li Y(*).Circulating microRNAs correlated with the level of coronary arterycalcification in symptomatic patients Sci rep 2015.

uGaoS(#), Shen J, Mukku VK,Wang MJ, Akhtar M,Liu W(*).Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: AMeta-Analysis of 8 Randomized Controlled Trials[J]. Angiology,2015:0003319715611826.

uLiu W(#),Wang Y, Zheng J, Song D, Zheng S, Ren L, Wang Y, Yao Y, Wang Y, Liu Y, Bai R,Dong J, Liu T(*). Syndecan-1 as an independent risk factor for the incidence ofadverse cardiovascular events in patients having stage C and D heart failurewith non-ischemic dilated cardiomyopathy[J]. Clinica Chimica Acta, 2018.12.19, 490:63~68. 

u